$BMRA
BIOMERICA INC

2022 Q3 Form 10-K Financial Statement

#000151316222000114 Filed on August 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $1.637M $5.302M $18.87M
YoY Change 29.74% 403.03% 162.13%
Cost Of Revenue $1.692M $4.681M $15.89M
YoY Change 25.29% 292.15% 132.62%
Gross Profit -$54.96K $621.4K $2.977M
YoY Change -38.23% -545.19% 712.87%
Gross Profit Margin -3.36% 11.72% 15.78%
Selling, General & Admin $1.654M $2.081M $5.699M
YoY Change 63.5% 22.63% 0.48%
% of Gross Profit 334.84% 191.41%
Research & Development $361.0K $297.0K $1.812M
YoY Change -17.93% -54.1% -17.41%
% of Gross Profit 47.8% 60.86%
Depreciation & Amortization $20.00K $236.8K $100.0K
YoY Change -42.4% 390.64% -4.76%
% of Gross Profit 38.11% 3.36%
Operating Expenses $2.015M $2.378M $7.511M
YoY Change 38.83% 1.45% -4.51%
Operating Profit -$2.070M -$1.756M -$4.534M
YoY Change 34.38% -29.28% -39.54%
Interest Expense $30.00 $6.900K
YoY Change -99.56% -45.84%
% of Operating Profit
Other Income/Expense, Net $28.00 $26.64K
YoY Change -99.59% -59.94%
Pretax Income -$2.070M -$1.749M -$4.507M
YoY Change 34.97% -29.19% -39.36%
Income Tax $1.957K $9.590K $24.00K
% Of Pretax Income
Net Earnings -$2.072M -$1.759M -$4.531M
YoY Change 34.31% -28.85% -39.15%
Net Earnings / Revenue -126.57% -33.18% -24.01%
Basic Earnings Per Share -$0.16 -$0.36
Diluted Earnings Per Share -$0.16 -$136.8K -$0.36
COMMON SHARES
Basic Shares Outstanding 13.39M shares 12.67M shares
Diluted Shares Outstanding 13.10M shares 12.67M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.075M $5.917M $5.917M
YoY Change 21.58% 40.9% 40.9%
Cash & Equivalents $6.075M $5.917M $5.917M
Short-Term Investments
Other Short-Term Assets $238.8K $320.3K $320.3K
YoY Change -24.26% -13.51% -13.51%
Inventory $1.922M $2.416M $2.416M
Prepaid Expenses
Receivables $932.3K $773.8K $773.8K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.168M $9.428M $9.428M
YoY Change 2.48% 2.13% 2.13%
LONG-TERM ASSETS
Property, Plant & Equipment $227.9K $214.0K $1.516M
YoY Change -87.18% -31.19% -18.63%
Goodwill
YoY Change
Intangibles $160.8K $170.0K
YoY Change -42.37%
Long-Term Investments $165.3K $165.3K $165.3K
YoY Change 0.0% 0.0% 0.0%
Other Assets $93.51K $95.59K $95.59K
YoY Change -64.92% -63.81% -63.81%
Total Long-Term Assets $1.882M $1.947M $1.947M
YoY Change -26.77% -24.78% -24.77%
TOTAL ASSETS
Total Short-Term Assets $9.168M $9.428M $9.428M
Total Long-Term Assets $1.882M $1.947M $1.947M
Total Assets $11.05M $11.37M $11.37M
YoY Change -4.05% -3.76% -3.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $671.2K $736.0K $736.0K
YoY Change 4.65% 70.77% 70.52%
Accrued Expenses $935.8K $236.0K $1.225M
YoY Change 11.32% 55.26% 40.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.758M $2.011M $2.011M
YoY Change 18.59% 54.69% 54.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $970.9K $1.038M $1.038M
YoY Change -21.12% -19.61% -19.61%
Total Long-Term Liabilities $970.9K $1.038M $1.038M
YoY Change -21.12% -19.61% -19.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.758M $2.011M $2.011M
Total Long-Term Liabilities $970.9K $1.038M $1.038M
Total Liabilities $2.728M $3.050M $3.050M
YoY Change 0.57% 17.66% 17.66%
SHAREHOLDERS EQUITY
Retained Earnings -$37.15M -$35.08M
YoY Change 14.83%
Common Stock $1.073M $1.029M
YoY Change 4.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.322M $8.325M $8.325M
YoY Change
Total Liabilities & Shareholders Equity $11.05M $11.37M $11.37M
YoY Change -4.05% -3.76% -3.76%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$2.072M -$1.759M -$4.531M
YoY Change 34.31% -28.85% -39.15%
Depreciation, Depletion And Amortization $20.00K $236.8K $100.0K
YoY Change -42.4% 390.64% -4.76%
Cash From Operating Activities -$1.573M -$4.258M -$480.5K
YoY Change -2174.52% 320.81% -90.85%
INVESTING ACTIVITIES
Capital Expenditures $33.62K -$24.36K $56.90K
YoY Change -143.37% -67.77% -58.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$33.62K -$24.36K -$170.3K
YoY Change -56.63% -67.77% -42.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.402M
YoY Change 103.99%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.778M 38.18K $2.395M
YoY Change 120.92% 923.59% 115.0%
NET CHANGE
Cash From Operating Activities -$1.573M -4.258M -$480.5K
Cash From Investing Activities -$33.62K -24.36K -$170.3K
Cash From Financing Activities $1.778M 38.18K $2.395M
Net Change In Cash $158.1K -4.244M $1.718M
YoY Change -80.32% 291.64% -138.67%
FREE CASH FLOW
Cash From Operating Activities -$1.573M -$4.258M -$480.5K
Capital Expenditures $33.62K -$24.36K $56.90K
Free Cash Flow -$1.607M -$4.233M -$537.4K
YoY Change -1147.82% 352.18% -90.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-05-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-37863
CY2022 dei Entity Registrant Name
EntityRegistrantName
BIOMERICA, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-2645573
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
17571 Von Karman Avenue
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
CY2022 dei City Area Code
CityAreaCode
949
CY2022 dei Local Phone Number
LocalPhoneNumber
645-2111
CY2022 dei Security12b Title
Security12bTitle
COMMON STOCK, PAR VALUE $0.08
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Trading Symbol
TradingSymbol
BMRA
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
55709903 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13391901 shares
CY2022 dei Auditor Name
AuditorName
HASKELL & WHITE LLP
CY2022 dei Auditor Firm
AuditorFirmId
200
CY2022 dei Auditor Location
AuditorLocation
Irvine, California
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5916983 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4199311 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
153231 usd
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
837415 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
773818 usd
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1455051 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2416447 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
3206255 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
320283 usd
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
370290 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
9427531 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
9230907 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1305360 usd
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1972357 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
214487 usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
310520 usd
CY2022Q2 bmra Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
724802 usd
CY2021Q2 bmra Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
469077 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1301834 usd
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1553081 usd
CY2022Q2 us-gaap Investments
Investments
165324 usd
CY2021Q2 us-gaap Investments
Investments
165324 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18994 usd
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
126769 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
169516 usd
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
294830 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95588 usd
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
264151 usd
CY2022Q2 us-gaap Assets
Assets
11374280 usd
CY2021Q2 us-gaap Assets
Assets
11818813 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
972372 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
583380 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
646944 usd
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
388896 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
50670 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
341296 usd
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
327944 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2011282 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1300220 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1038284 usd
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1291570 usd
CY2022Q2 us-gaap Liabilities
Liabilities
3049566 usd
CY2021Q2 us-gaap Liabilities
Liabilities
2591790 usd
CY2022Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q2 bmra Preferred Stock Undesignated Shares
PreferredStockUndesignatedShares
4428571 shares
CY2021Q2 bmra Preferred Stock Undesignated Shares
PreferredStockUndesignatedShares
4428571 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.08
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.08
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12867924 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12867924 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12307157 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12307157 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1029432 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
984571 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42446597 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38836743 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-73936 usd
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47956 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35077379 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30546335 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
8324714 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9227023 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11374280 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11818813 usd
CY2022 us-gaap Revenues
Revenues
18871409 usd
CY2021 us-gaap Revenues
Revenues
7199027 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
15893991 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
6832742 usd
CY2022 us-gaap Gross Profit
GrossProfit
2977418 usd
CY2021 us-gaap Gross Profit
GrossProfit
366285 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5698958 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5671517 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1812424 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2194461 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
7511382 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
7865978 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4533964 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7499693 usd
CY2022 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
26639 usd
CY2021 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
66863 usd
CY2021 us-gaap Interest Expense
InterestExpense
367 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26639 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
66496 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4507325 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7433197 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23719 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13057 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4531044 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7446254 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12673245 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11928941 shares
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12673245 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11928941 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4531044 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7446254 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-25980 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8115 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4557024 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7454369 usd
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
14213053 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102255 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1011475 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8115 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1354609 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7446254 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9227023 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
77360 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2317160 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-25980 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1260195 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4531044 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
8324714 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4531044 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7446254 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
339096 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
138267 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-52587 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-684184 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
766434 usd
CY2022 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-771736 usd
CY2021 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
1550594 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1260195 usd
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1354609 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
255725 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
237588 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1365417 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
455614 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1561544 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1906013 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-50007 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1138793 usd
CY2022 bmra Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
-244412 usd
CY2021 bmra Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
-241132 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-168563 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
95958 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
388992 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-403331 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
258048 usd
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
110269 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
50670 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-480532 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5251748 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
113436 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
159727 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56900 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
135856 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-170336 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-295583 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2401734 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1177394 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
84574 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
165919 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77360 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102255 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2394520 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1113730 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-25980 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8115 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1717672 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4441716 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199311 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8641027 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5916983 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199311 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
23719 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
27171 usd
CY2022 bmra Increase In Right Of Use Asset
IncreaseInRightOfUseAsset
4478 usd
CY2021 bmra Increase In Right Of Use Asset
IncreaseInRightOfUseAsset
79159 usd
CY2022 bmra Increase In Lease Liability
IncreaseInLeaseLiability
4478 usd
CY2021 bmra Increase In Lease Liability
IncreaseInLeaseLiability
79159 usd
CY2022 bmra Write Off Of Fixed Assets Cost
WriteOffOfFixedAssetsCost
819931 usd
CY2022 bmra Write Off Of Fixed Assets Accumulated Depreciation
WriteOffOfFixedAssetsAccumulatedDepreciation
767344 usd
CY2022 bmra Write Off Of Intangible Assets Cost
WriteOffOfIntangibleAssetsCost
246756 usd
CY2022 bmra Write Off Of Intangible Assets Accumulated Amortization
WriteOffOfIntangibleAssetsAccumulatedAmortization
37221 usd
CY2022 us-gaap Revenues
Revenues
18871000 usd
CY2021 us-gaap Revenues
Revenues
7199000 usd
CY2022Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
927000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><b><span style="FONT-SIZE:10pt; COLOR:black">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"> </p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"> </p><p style="font-size: 12pt; font-family: 'Times New Roman',serif; text-align: justify; margin: 0in;"><span style="font-size: 10pt;">Due to the Coronavirus global pandemic, the Company’s operations have been negatively impacted. <span style="color: black;">The Company has faced disruptions in the following areas, (and may face further challenges): supply chain disruptions, loss of contracts and/or customers, closure of the Company’s manufacturing or distribution facilities or of the facilities of the Company’s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions can materially negatively impact the Company’s operations and financial performance and may continue to have significant material negative impacts on the Company.   </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"> </p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5917000 usd
CY2022 bmra Working Capital
WorkingCapital
7416000 usd
CY2021Q1 bmra Shelf Registration Statement Maximum Authorized Common Stock Issuance Value
ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue
15000000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><b><span style="FONT-SIZE:10pt; COLOR:black">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"> </p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies.  As of May 31, 2022, the Company had approximately $5,702,000 of uninsured cash. The Company does not believe it is exposed to any significant credit risks.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"> </p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company provides credit in the normal course of business to customers throughout the United States and in foreign markets.  The Company performs ongoing credit evaluations of its customers and requires accelerated prepayment in some circumstances. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; MARGIN:0in"/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><span style="FONT-SIZE:10pt; COLOR:black">Our net sales were approximately $18,871,000 for fiscal 2022 compared to $7,199,000 for fiscal 2021. For the fiscal years ended May 31, 2022 and 2021, the Company had two distributors, which accounted for a total of 65% and 60% of our net sales, respectively. Of this, for the fiscal years ended May 31, 2022 and 2021, the largest of the distributors mentioned above accounted for 55% and 33%, respectively, of net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; MARGIN:0in"/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><span style="FONT-SIZE:10pt; COLOR:black">Total gross receivables on May 31, 2022 and 2021 were approximately $927,000 and $2,292,000, respectively. On May 31, 2022 and 2021, the Company had one distributor and two distributors, respectively, which accounted for a total of 50% and 73%, respectively, of gross accounts receivable. Of the 50% as of May 31, 2022, 50% was owed by a distributor in Asia.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; PAGE-BREAK-BEFORE:none; TEXT-ALIGN:center; MARGIN:0in; text-align: center;"> </p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"><span style="FONT-SIZE:10pt; COLOR:black">For the fiscal years ended May 31, 2022 and 2021, the Company had one vendor, which accounted for 84% and 58%, respectively, of our purchases of raw materials.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,serif; TEXT-ALIGN:justify; MARGIN:0in"> </p>
CY2022Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5702000 usd
CY2022 us-gaap Threshold Period Past Due For Writeoff Of Trade Accounts Receivable
ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable
P90D
CY2022 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
320000 usd
CY2021 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
370000 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1717000 usd
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1812000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
763000 usd
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1687000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
782000 usd
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1324000 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
3262000 usd
CY2021Q2 us-gaap Inventory Gross
InventoryGross
4823000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
846000 usd
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1617000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2416000 usd
CY2021Q2 us-gaap Inventory Net
InventoryNet
3206000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
846000 usd
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1617000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
239000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34000 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
210000 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1260000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1355000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
5.22
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
746462 shares
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
5.11
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18871000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7199000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1812000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2194000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6967000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6967000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
76000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
10000 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2321616 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2081366 shares
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin: 0in; text-align: justify;"><span style="font-family: times new roman, times, serif; font-size: 10pt;"><strong><span style="color: black;">RECLASSIFICATIONS</span></strong></span></p><p style="margin: 0in; text-align: justify;"><span style="font-family: times new roman, times, serif; font-size: 10pt;"><strong><span style="color: black;"> </span></strong></span></p><p style="margin: 0in; text-align: justify;"><span style="font-size: 10.0pt; color: black;"><span style="font-family: times new roman, times, serif;">Certain comparative figures in the 2021 Statement of Operations have been reclassified to conform to the current year’s presentation.</span> </span></p>
CY2022Q2 bmra Equipment
Equipment
1292000 usd
CY2021Q2 bmra Equipment
Equipment
1850000 usd
CY2022Q2 bmra Furniture Fixtures And Leasehold Improvements
FurnitureFixturesAndLeaseholdImprovements
227000 usd
CY2021Q2 bmra Furniture Fixtures And Leasehold Improvements
FurnitureFixturesAndLeaseholdImprovements
433000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1305000 usd
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1972000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
214000 usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-13000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-217000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-88000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
11000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
736000 usd
CY2021Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
182000 usd
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
189000 usd
CY2021Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
240000 usd
CY2021Q2 bmra Finite Lived License Accumulated Amortization
FiniteLivedLicenseAccumulatedAmortization
107000 usd
CY2022Q2 bmra Finite Lived Patents Accumulated Amortization
FiniteLivedPatentsAccumulatedAmortization
19000 usd
CY2021Q2 bmra Finite Lived Patents Accumulated Amortization
FiniteLivedPatentsAccumulatedAmortization
20000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
170000 usd
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
295000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
13000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
13000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
13000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
105000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
170000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
145000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-113000 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-12000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-24000 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
431000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
236000 usd
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
152000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
972000 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
583000 usd
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
793241 shares
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
5.54
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
344000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.43
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
347279 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
5.4
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
43500 shares
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-23000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-12000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-24000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-13000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
947000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1561000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1022000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2292000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
300000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
217000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
50000 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
456000 usd
CY2022Q2 bmra Deferred Tax Assets Losses Of Foreign Subsidiaries Other Net
DeferredTaxAssetsLossesOfForeignSubsidiariesOtherNet
41000 usd
CY2021Q2 bmra Deferred Tax Assets Losses Of Foreign Subsidiaries Other Net
DeferredTaxAssetsLossesOfForeignSubsidiariesOtherNet
370000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
43000 usd
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
200000 usd
CY2022Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
237000 usd
CY2021Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
387000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
120000 usd
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
85000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4349000 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3194000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1096000 usd
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1055000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
20000 usd
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
15000 usd
CY2022Q2 bmra Deffered Tax Assets Stock Options
DefferedTaxAssetsStockOptions
1035000 usd
CY2021Q2 bmra Deffered Tax Assets Stock Options
DefferedTaxAssetsStockOptions
613000 usd
CY2022Q2 bmra Deferred Tax Assets Accumulated Depreciation And Amortization
DeferredTaxAssetsAccumulatedDepreciationAndAmortization
26000 usd
CY2021Q2 bmra Deferred Tax Assets Accumulated Depreciation And Amortization
DeferredTaxAssetsAccumulatedDepreciationAndAmortization
-15000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6967000 usd
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5904000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6967000 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5904000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6967000 usd
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5904000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1063000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2292000 usd
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022 us-gaap Revenues
Revenues
18871000 usd
CY2021 us-gaap Revenues
Revenues
7199000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
338206 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M10D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065 pure
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
351000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
362000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
373000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
384000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
104000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1574000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
194000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1380000 usd
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
usd
CY2022 us-gaap Interest Expense
InterestExpense
usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
CY2021 bmra Write Off Of Fixed Assets Cost
WriteOffOfFixedAssetsCost
usd
CY2021 bmra Write Off Of Fixed Assets Accumulated Depreciation
WriteOffOfFixedAssetsAccumulatedDepreciation
usd
CY2021 bmra Write Off Of Intangible Assets Cost
WriteOffOfIntangibleAssetsCost
usd
CY2021 bmra Write Off Of Intangible Assets Accumulated Amortization
WriteOffOfIntangibleAssetsAccumulatedAmortization
usd
CY2022Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
usd
CY2022Q2 bmra Finite Lived License Accumulated Amortization
FiniteLivedLicenseAccumulatedAmortization
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000073290
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd

Files In Submission

Name View Source Status
0001513162-22-000114-index-headers.html Edgar Link pending
0001513162-22-000114-index.html Edgar Link pending
0001513162-22-000114.txt Edgar Link pending
0001513162-22-000114-xbrl.zip Edgar Link pending
bmra-20220531.htm Edgar Link pending
bmra-20220531.xsd Edgar Link pending
exhibit23_1.htm Edgar Link pending
exhibit23_2.htm Edgar Link pending
exhibit31_1.htm Edgar Link pending
exhibit31_2.htm Edgar Link pending
exhibit32_1.htm Edgar Link pending
exhibit32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
bmra-20220531_lab.xml Edgar Link unprocessable
bmra-20220531_pre.xml Edgar Link unprocessable
bmra-20220531_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bmra-20220531_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bmra-20220531_cal.xml Edgar Link unprocessable